App-Quantinova.ai

Class II Major Histocompatibility Complex Transactivator (CIITA) Knockdown Prevents Immune Rejection of Allogeneic Bone Marrow Stem Cells in Cardiac Regeneration

Xi-Ping Huang - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

5-Azacytidine

Vagal Nerve Stimulation Mitigates Atrial Fibrillation by Attenuating the Intrinsic Cardiac Local Circuit Neuronal Activity

Eric Beaumont - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

N/A

The Relationship of Platelet Function Measurements with Bleeding Outcomes During Long-term Treatment with Dual Antiplatelet Therapy in Medically Managed NSTE-ACS Patients

E. Magnus Ohman - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Gastrointestinal bleeding

Clopidogrel bisulfate

Angiographic and Hemodynamic Features of Symptomatic Vertebrobasilar Disease: Baseline Data from the VERiTAS Study

Xinjian Du - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Transient Ischemic Attack

N/A

Impact of Prasugrel Pretreatment and Timing of Coronary Artery Bypass Grafting on Clinical Outcomes of Patients With Non-ST-Segment Elevation Myocardial Infarction: From the Accoast Study

Petr Widimsky - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Myocardial infarction

Prasugrel

Impact Of Drug Policy On Regional Trends In Ezetimibe Use

Harlan Krumholz - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

Ezetimibe

Sex, Gender, Socioeconomic Status and Access to Cardiac Catheterization in the Context of Universal Healthcare Coverage

Alexander A. Leung - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Acute Coronary Syndromes

N/A

MiR-33 Coordinately Regulates Macrophage Autophagy

Hasini Ediriweera - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

lipase

Risk of Intracranial Hemorrhage Among Acute Ischemic Stroke Patients Receiving Prior Antiplatelet Therapy and Treated with Intravenous Tissue Plasminogen Activator

Maria Grau-Spulveda - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Ischemic stroke

Methadone hydrochloride

ABCA1 Ligand Peptides That Stimulate Cellular Cholesterol Efflux With High Potency Increase Insulin Sensitivity in Metabolic and Genetic Mouse Models of Obesity and Type 2 Diabetes

Stefanie Bittner - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

N/A

A Novel Lysosome-Mediated Degradation Mechanism for Hepatic Lipid Droplet Turnover

Zemin Yao - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

nocodazole

Elucidation of the Mechanism of Apolipoprotein(a)/Lipoprotein(a)-Induced Interleukin 8 Gene Expression: Insight into Potential Receptors and Signaling Pathways and the Role of Oxidized Phospholipids

Sera Sayegh - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

Interleukin

Low Systemic Arterial Pressure and Greater Vascular Stiffness after Transcatheter Aortic Valve Replacement are Independently Associated with Mortality in the PARTNER I Trial and Registry

Pamela S. Douglas - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Patient prosthesis mismatch

N/A

Does Pharmacological Ventricular Rate Control Mitigate AF-Induced Remodeling in the Absence of Tachycardiomyopathy?

Stanley Nattel - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

ADIZEM

Epicardial Infarct Repair with a Novel Biologic Extracellular Matrix Improves Infarct Healing: Preclinical Validation

Jeannine D Turnbull - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Ischemia-reperfusion injury

N/A

Incidence and Characteristics of Pulmonary Vein Stenosis Following Catheter Ablation of Atrial Fibrillation: Insights From the Contemporary Multicenter ADVICE Trial

Paul Khairy - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary vein stenosis

N/A

Medical Therapy and Coronary Revascularization for Patients with Stable Coronary Artery Disease and Unclassified Appropriateness Score

Helen Guo - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Stable coronary artery disease

N/A

A Novel Quadripolar Lead with a Narrow-Spaced Bipole Allows for Effective LV Pacing While Avoiding Phrenic Nerve Stimulation - Attain Performa LV Lead Study Primary Results

Maurio Biffi - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congestive heart failure

Stribild

Young Women with Stable CHD are More Likely to Develop Myocardial Ischemia with Mental Stress Than Men of Similar Age

Pratik M Pimple - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

sestamibi

Inverse Association between Family History of Premature Coronary Artery Disease and the Risk of Death in Patients with Coronary Artery Disease

Abdel Aziz Shaheen - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Congestive heart failure

N/A

Filters

28841 Abstracts